JASON DOWD

Vice-President of Science & Technology, Centre for Commercialization of Regenerative Medicine (CCRM)

Jason has over 20 years of industry experience in regenerative medicine, research, development and Good Manufacturing Practices.  He has successfully brought cutting-edge technologies and therapeutic products to European, Canadian and U.S. markets.  Dedicated to innovation, Jason joined CCRM to advance technology translation and bridge the technology  and process development pipeline to the manufacturing stage of cell and gene therapies for clinical use.